HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 27-OCT-10 3AQA TITLE CRYSTAL STRUCTURE OF THE HUMAN BRD2 BD1 BROMODOMAIN IN COMPLEX WITH A TITLE 2 BRD2-INTERACTIVE COMPOUND, BIC1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 73-194; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: BACTERIAL CELL FREE SYSTEM KEYWDS STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, KEYWDS 2 RSGI, HELICAL BUNDLE, ACETYL-LYSINE RECOGNITION, ACETYLATED HISTONE KEYWDS 3 H4, NUCLEUS, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.UMEHARA,Y.NAKAMURA,T.TERADA,M.SHIROUZU,B.PADMANABHAN,S.YOKOYAMA, AUTHOR 2 RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 15-NOV-23 3AQA 1 REMARK REVDAT 2 01-NOV-23 3AQA 1 REMARK SEQADV LINK REVDAT 1 18-MAY-11 3AQA 0 JRNL AUTH T.ITO,T.UMEHARA,K.SASAKI,Y.NAKAMURA,N.NISHINO,T.TERADA, JRNL AUTH 2 M.SHIROUZU,B.PADMANABHAN,S.YOKOYAMA,A.ITO,M.YOSHIDA JRNL TITL REAL-TIME IMAGING OF HISTONE H4K12-SPECIFIC ACETYLATION JRNL TITL 2 DETERMINES THE MODES OF ACTION OF HISTONE DEACETYLASE AND JRNL TITL 3 BROMODOMAIN INHIBITORS JRNL REF CHEM.BIOL. V. 18 495 2011 JRNL REFN ISSN 1074-5521 JRNL PMID 21513886 JRNL DOI 10.1016/J.CHEMBIOL.2011.02.009 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 414406.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 18668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1845 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2670 REMARK 3 BIN R VALUE (WORKING SET) : 0.1970 REMARK 3 BIN FREE R VALUE : 0.2550 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 298 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 105 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.86000 REMARK 3 B22 (A**2) : -0.47000 REMARK 3 B33 (A**2) : -2.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.40000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.080 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.710 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.810 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.47 REMARK 3 BSOL : 53.80 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DRG_PARAM.TXT REMARK 3 PARAMETER FILE 3 : MES_XPLOR_PARAM.TXT REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DRG_TOP.TXT REMARK 3 TOPOLOGY FILE 3 : MES_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 4 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3AQA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1000029561. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18668 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 31.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1X0J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG MME 5000, 0.2M AMMONIUM REMARK 280 SULFATE, 0.1M HEPES BUFFER, PH 7.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.29850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.85800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.29850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.85800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 114.59700 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 67 REMARK 465 SER A 68 REMARK 465 SER A 69 REMARK 465 GLY A 70 REMARK 465 SER A 71 REMARK 465 SER A 72 REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 GLY B 67 REMARK 465 SER B 68 REMARK 465 SER B 69 REMARK 465 GLY B 70 REMARK 465 SER B 71 REMARK 465 SER B 72 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 GLY C 67 REMARK 465 SER C 68 REMARK 465 SER C 69 REMARK 465 GLY C 70 REMARK 465 SER C 71 REMARK 465 SER C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 74 153.23 173.71 REMARK 500 VAL A 85 -73.44 -98.35 REMARK 500 GLU A 183 -8.74 -147.94 REMARK 500 GLU A 184 52.65 20.82 REMARK 500 VAL B 75 123.50 74.51 REMARK 500 LEU B 110 70.78 -118.91 REMARK 500 LEU C 110 68.81 -110.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BYH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSO003006073.2 RELATED DB: TARGETDB DBREF 3AQA A 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 3AQA B 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 3AQA C 73 194 UNP P25440 BRD2_HUMAN 73 194 SEQADV 3AQA GLY A 67 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER A 68 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER A 69 UNP P25440 EXPRESSION TAG SEQADV 3AQA GLY A 70 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER A 71 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER A 72 UNP P25440 EXPRESSION TAG SEQADV 3AQA GLY B 67 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER B 68 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER B 69 UNP P25440 EXPRESSION TAG SEQADV 3AQA GLY B 70 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER B 71 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER B 72 UNP P25440 EXPRESSION TAG SEQADV 3AQA GLY C 67 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER C 68 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER C 69 UNP P25440 EXPRESSION TAG SEQADV 3AQA GLY C 70 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER C 71 UNP P25440 EXPRESSION TAG SEQADV 3AQA SER C 72 UNP P25440 EXPRESSION TAG SEQRES 1 A 128 GLY SER SER GLY SER SER GLY ARG VAL THR ASN GLN LEU SEQRES 2 A 128 GLN TYR LEU HIS LYS VAL VAL MSE LYS ALA LEU TRP LYS SEQRES 3 A 128 HIS GLN PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA SEQRES 4 A 128 VAL LYS LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS SEQRES 5 A 128 GLN PRO MSE ASP MSE GLY THR ILE LYS ARG ARG LEU GLU SEQRES 6 A 128 ASN ASN TYR TYR TRP ALA ALA SER GLU CYS MSE GLN ASP SEQRES 7 A 128 PHE ASN THR MSE PHE THR ASN CYS TYR ILE TYR ASN LYS SEQRES 8 A 128 PRO THR ASP ASP ILE VAL LEU MSE ALA GLN THR LEU GLU SEQRES 9 A 128 LYS ILE PHE LEU GLN LYS VAL ALA SER MSE PRO GLN GLU SEQRES 10 A 128 GLU GLN GLU LEU VAL VAL THR ILE PRO LYS ASN SEQRES 1 B 128 GLY SER SER GLY SER SER GLY ARG VAL THR ASN GLN LEU SEQRES 2 B 128 GLN TYR LEU HIS LYS VAL VAL MSE LYS ALA LEU TRP LYS SEQRES 3 B 128 HIS GLN PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA SEQRES 4 B 128 VAL LYS LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS SEQRES 5 B 128 GLN PRO MSE ASP MSE GLY THR ILE LYS ARG ARG LEU GLU SEQRES 6 B 128 ASN ASN TYR TYR TRP ALA ALA SER GLU CYS MSE GLN ASP SEQRES 7 B 128 PHE ASN THR MSE PHE THR ASN CYS TYR ILE TYR ASN LYS SEQRES 8 B 128 PRO THR ASP ASP ILE VAL LEU MSE ALA GLN THR LEU GLU SEQRES 9 B 128 LYS ILE PHE LEU GLN LYS VAL ALA SER MSE PRO GLN GLU SEQRES 10 B 128 GLU GLN GLU LEU VAL VAL THR ILE PRO LYS ASN SEQRES 1 C 128 GLY SER SER GLY SER SER GLY ARG VAL THR ASN GLN LEU SEQRES 2 C 128 GLN TYR LEU HIS LYS VAL VAL MSE LYS ALA LEU TRP LYS SEQRES 3 C 128 HIS GLN PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA SEQRES 4 C 128 VAL LYS LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS SEQRES 5 C 128 GLN PRO MSE ASP MSE GLY THR ILE LYS ARG ARG LEU GLU SEQRES 6 C 128 ASN ASN TYR TYR TRP ALA ALA SER GLU CYS MSE GLN ASP SEQRES 7 C 128 PHE ASN THR MSE PHE THR ASN CYS TYR ILE TYR ASN LYS SEQRES 8 C 128 PRO THR ASP ASP ILE VAL LEU MSE ALA GLN THR LEU GLU SEQRES 9 C 128 LYS ILE PHE LEU GLN LYS VAL ALA SER MSE PRO GLN GLU SEQRES 10 C 128 GLU GLN GLU LEU VAL VAL THR ILE PRO LYS ASN MODRES 3AQA MSE A 87 MET SELENOMETHIONINE MODRES 3AQA MSE A 121 MET SELENOMETHIONINE MODRES 3AQA MSE A 123 MET SELENOMETHIONINE MODRES 3AQA MSE A 142 MET SELENOMETHIONINE MODRES 3AQA MSE A 148 MET SELENOMETHIONINE MODRES 3AQA MSE A 165 MET SELENOMETHIONINE MODRES 3AQA MSE A 180 MET SELENOMETHIONINE MODRES 3AQA MSE B 87 MET SELENOMETHIONINE MODRES 3AQA MSE B 121 MET SELENOMETHIONINE MODRES 3AQA MSE B 123 MET SELENOMETHIONINE MODRES 3AQA MSE B 142 MET SELENOMETHIONINE MODRES 3AQA MSE B 148 MET SELENOMETHIONINE MODRES 3AQA MSE B 165 MET SELENOMETHIONINE MODRES 3AQA MSE B 180 MET SELENOMETHIONINE MODRES 3AQA MSE C 87 MET SELENOMETHIONINE MODRES 3AQA MSE C 121 MET SELENOMETHIONINE MODRES 3AQA MSE C 123 MET SELENOMETHIONINE MODRES 3AQA MSE C 142 MET SELENOMETHIONINE MODRES 3AQA MSE C 148 MET SELENOMETHIONINE MODRES 3AQA MSE C 165 MET SELENOMETHIONINE MODRES 3AQA MSE C 180 MET SELENOMETHIONINE HET MSE A 87 8 HET MSE A 121 8 HET MSE A 123 8 HET MSE A 142 8 HET MSE A 148 8 HET MSE A 165 8 HET MSE A 180 8 HET MSE B 87 8 HET MSE B 121 8 HET MSE B 123 8 HET MSE B 142 8 HET MSE B 148 8 HET MSE B 165 8 HET MSE B 180 8 HET MSE C 87 8 HET MSE C 121 8 HET MSE C 123 8 HET MSE C 142 8 HET MSE C 148 8 HET MSE C 165 8 HET MSE C 180 8 HET BYH A 201 23 HET MES A 401 12 HETNAM MSE SELENOMETHIONINE HETNAM BYH 1-[2-(1H-BENZIMIDAZOL-2-YLSULFANYL)ETHYL]-3-METHYL-1,3- HETNAM 2 BYH DIHYDRO-2H-BENZIMIDAZOLE-2-THIONE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID FORMUL 1 MSE 21(C5 H11 N O2 SE) FORMUL 4 BYH C17 H16 N4 S2 FORMUL 5 MES C6 H13 N O4 S FORMUL 6 HOH *105(H2 O) HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 HIS A 93 1 9 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 104 GLY A 109 1 6 HELIX 5 5 ASP A 112 ILE A 117 1 6 HELIX 6 6 ASP A 122 ASN A 132 1 11 HELIX 7 7 ALA A 137 ASN A 156 1 20 HELIX 8 8 ASP A 160 ALA A 178 1 19 HELIX 9 9 THR B 76 VAL B 85 1 10 HELIX 10 10 VAL B 85 LYS B 92 1 8 HELIX 11 11 ALA B 96 ARG B 100 5 5 HELIX 12 12 ASP B 104 GLY B 109 1 6 HELIX 13 13 ASP B 112 ILE B 117 1 6 HELIX 14 14 ASP B 122 ASN B 132 1 11 HELIX 15 15 ALA B 137 ASN B 156 1 20 HELIX 16 16 ASP B 160 ALA B 178 1 19 HELIX 17 17 THR C 76 VAL C 85 1 10 HELIX 18 18 VAL C 85 HIS C 93 1 9 HELIX 19 19 ASP C 112 ILE C 117 1 6 HELIX 20 20 ASP C 122 ASN C 132 1 11 HELIX 21 21 ALA C 137 ASN C 156 1 20 HELIX 22 22 ASP C 160 SER C 179 1 20 LINK C VAL A 86 N MSE A 87 1555 1555 1.33 LINK C MSE A 87 N LYS A 88 1555 1555 1.33 LINK C PRO A 120 N MSE A 121 1555 1555 1.33 LINK C MSE A 121 N ASP A 122 1555 1555 1.33 LINK C ASP A 122 N MSE A 123 1555 1555 1.32 LINK C MSE A 123 N GLY A 124 1555 1555 1.33 LINK C CYS A 141 N MSE A 142 1555 1555 1.32 LINK C MSE A 142 N GLN A 143 1555 1555 1.33 LINK C THR A 147 N MSE A 148 1555 1555 1.32 LINK C MSE A 148 N PHE A 149 1555 1555 1.33 LINK C LEU A 164 N MSE A 165 1555 1555 1.32 LINK C MSE A 165 N ALA A 166 1555 1555 1.33 LINK C SER A 179 N MSE A 180 1555 1555 1.32 LINK C MSE A 180 N PRO A 181 1555 1555 1.34 LINK C VAL B 86 N MSE B 87 1555 1555 1.32 LINK C MSE B 87 N LYS B 88 1555 1555 1.32 LINK C PRO B 120 N MSE B 121 1555 1555 1.33 LINK C MSE B 121 N ASP B 122 1555 1555 1.32 LINK C ASP B 122 N MSE B 123 1555 1555 1.32 LINK C MSE B 123 N GLY B 124 1555 1555 1.33 LINK C CYS B 141 N MSE B 142 1555 1555 1.33 LINK C MSE B 142 N GLN B 143 1555 1555 1.33 LINK C THR B 147 N MSE B 148 1555 1555 1.33 LINK C MSE B 148 N PHE B 149 1555 1555 1.34 LINK C LEU B 164 N MSE B 165 1555 1555 1.32 LINK C MSE B 165 N ALA B 166 1555 1555 1.33 LINK C SER B 179 N MSE B 180 1555 1555 1.32 LINK C MSE B 180 N PRO B 181 1555 1555 1.34 LINK C VAL C 86 N MSE C 87 1555 1555 1.33 LINK C MSE C 87 N LYS C 88 1555 1555 1.33 LINK C PRO C 120 N MSE C 121 1555 1555 1.33 LINK C MSE C 121 N ASP C 122 1555 1555 1.31 LINK C ASP C 122 N MSE C 123 1555 1555 1.33 LINK C MSE C 123 N GLY C 124 1555 1555 1.33 LINK C CYS C 141 N MSE C 142 1555 1555 1.33 LINK C MSE C 142 N GLN C 143 1555 1555 1.32 LINK C THR C 147 N MSE C 148 1555 1555 1.33 LINK C MSE C 148 N PHE C 149 1555 1555 1.33 LINK C LEU C 164 N MSE C 165 1555 1555 1.33 LINK C MSE C 165 N ALA C 166 1555 1555 1.34 LINK C SER C 179 N MSE C 180 1555 1555 1.33 LINK C MSE C 180 N PRO C 181 1555 1555 1.34 SITE 1 AC1 7 TRP A 97 PRO A 98 LEU A 108 ASN A 156 SITE 2 AC1 7 MSE A 165 HOH A 198 GLN B 94 SITE 1 AC2 6 HOH A 5 TRP A 97 ARG A 100 HOH A 199 SITE 2 AC2 6 ARG C 128 ASN C 132 CRYST1 114.597 55.716 68.205 90.00 94.17 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008726 0.000000 0.000636 0.00000 SCALE2 0.000000 0.017948 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014701 0.00000